Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 24;8(2):e52.
doi: 10.1192/bjo.2022.18.

Randomised controlled trials of mood stabilisers for people with autism spectrum disorder: systematic review and meta-analysis

Bharati Limbu  1 , Shoumitro Deb  2 , Meera Roy  3 , Rachel Lee  4 , Ashok Roy  5 , Oluwafemi Taiwo  6
Affiliations
Review

Randomised controlled trials of mood stabilisers for people with autism spectrum disorder: systematic review and meta-analysis

Bharati Limbu et al. BJPsych Open. .

Abstract

Background: Despite the widespread use of psychotropic medications in people with autism spectrum disorder (ASD), there is limited evidence to suggest that psychotropic medications including mood stabilisers are effective in individuals with ASD.

Aims: To carry out a systematic review and meta-analysis of randomised controlled trials (RCTs) that assessed the effectiveness of mood stabilisers in people with ASD.

Method: We searched the following databases: Cochrane Library, MEDLINE, Embase, CINAHL, PsycINFO, ERIC, DARE, and ClinicalTrials.gov. In addition, we hand-searched 12 relevant journals. We used the Cochrane Risk of Bias and Jadad scores to assess the quality of included RCTs. We carried out a meta-analysis using a random-effects model.

Results: We included eight RCTs (four on valproate, two on levetiracetam, and one each on lamotrigine and topiramate) that included a total of 310 people with ASD, primarily children. Outcomes were based on core and associated ASD symptoms including irritability and aggression but not bipolar disorder. Only two small studies (25%) from the same group showed definite superiority over placebo and one over psychoeducation alone. Meta-analysis of pooled data on the Aberrant Behaviour Checklist-irritability, Clinical Global Impression Scale-improvement, and Overt Aggression Scale (OAS)/OAS-modified did not show any significant inter-group difference. The rates of adverse effects did not show any significant inter-group difference.

Conclusions: Given the methodological flaws in the included studies and the contradictory findings, it is difficult to draw any definitive conclusion about the effectiveness of mood stabilisers to treat either ASD core symptoms or associated behaviours. Robust large-scale RCTs are needed in the future to address this issue.PROSPERO registration: CRD42021255467 on 18 May 2021.

Keywords: Autism spectrum disorder; RCTs; anti-epileptics; mood stabilisers; systematic review.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
PRISMA flow chart of the article selection process.
Fig. 2
Fig. 2
Cochrane risk-of-bias summary scores and graph.
Fig. 3
Fig. 3
Forest plots (a) ABC-I meta-analysis, (b) OAS/OAS-M meta-analysis and (c) CGI-I.
See this image and copyright information in PMC

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American Psychiatric Publishing, 2013.
    1. World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics 11th Revision. WHO, 2019. Available from: https://icd.who.int/browse11/l-m/en [cited 11 Mar 2021].
    1. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 2008; 47: 921–9. - PubMed
    1. Lai MC, Kassee C, Besney R, Bonato S, Hull L, Mandy W, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry 2019; 6: 819–29. - PubMed
    1. Lugo-Marína J, Magán-Magantob M, Rivero-Santanac A, Cuellar-Pompac L, Alviania M, Jenaro-Riob C, et al. Prevalence of psychiatric disorders in adults with autism spectrum disorder: a systematic review and meta-analysis. Res Autism Spectr Disord 2019; 59: 22–33.